flag flag  

Adriamycin, cyclophosphamide and vindesine (ACV) versus mitoxantrone, cyclophosphamide and vindesine (NCV) in advanced breast-cancer

Description : The choice of chemotherapy for advanced breast cancer patients is based on both response rates and anticipated side effects. Two polychemotherapy regimens, ACV and NCV, were compared in an open study with 90 patients of whom 69 were evaluable both for efficacy and toxicity. Both ACV and NCV are acti...
Language(s) : English
Subject(s) : ADVANCED BREAST CANCER; ADRIAMYCIN; MITOXANTRONE; COMBINATION CHEMOTHERAPY
Publisher(s) : INT INST ANTICANCER RESEARCH
Contributor(s) :
Source(s) :
Publication Date(s) : 2007-11-29